Research Beam added a report on “Sarcopenia - Pipeline Review, H2 2015”
Enquiry about report: http://www.researchbeam.com/sarcopenia-pipeline-review-h2-2015-market/enquire-about-report
2. Report Overview
Scope
- The report provides a snapshot of the global therapeutic landscape of Sarcopenia
- The report reviews key pipeline products under drug profile section which includes, product description,
MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Sarcopenia and enlists all
their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Sarcopenia products under development by companies and universities/research
institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till
discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Sarcopenia pipeline on the basis of target, MoA, route of administration and molecule
type
- Latest news and deals relating related to pipeline products
Read More At : http://www.researchbeam.com/sarcopenia-pipeline-review-h2-2015-market
3. Table of Content
List of Figures
Number of Products under Development for Sarcopenia, H2 2015 8
Number of Products under Development for Sarcopenia - Comparative Analysis, H2 2015 9
Number of Products under Development by Companies, H2 2015 10
Comparative Analysis by Clinical Stage Development, H2 2015 12
Comparative Analysis by Early Stage Products, H2 2015 13
Assessment by Monotherapy Products, H2 2015 24
Number of Products by Top 10 Targets, H2 2015 25
Number of Products by Stage and Top 10 Targets, H2 2015 25
Number of Products by Top 10 Mechanism of Actions, H2 2015 27
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015 27
Number of Products by Top 10 Routes of Administration, H2 2015 29
Number of Products by Stage and Top 10 Routes of Administration, H2 2015 29
Number of Products by Top 10 Molecule Types, H2 2015 31
Number of Products by Stage and Top 10 Molecule Types, H2 2015 31
4. Report Overview
Reasons to buy
- Provides strategically significant competitor information, analysis, and insights to formulate effective
R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-
strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Sarcopenia
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Sarcopenia pipeline depth and focus
of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the
most attractive projects to enhance and expand business potential and Scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that
drove them from pipeline
Enquire At : http://www.researchbeam.com/sarcopenia-pipeline-review-h2-2015-market/enquire-
about-report
5. FOR MORE DETAILS
Visit us at :
Stay With Us:
http://www.researchbeam.com/sarcopenia-pipeline-review-h2-2015-market
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
TELEPHONE: +1 (800) 910-6452
DIRECT: +1 (503) 894-6022
E-MAIL: sales@researchbeam.com